Abstract Details
Julia E. Thompson, MD
PRESENTER |
No disclosure on file |
No disclosure on file | |
Mateusz Makuch | No disclosure on file |
Andrew Murchison | No disclosure on file |
Christian Bien, MD (Epilepsy Centre Bethel) | Dr. Bien has nothing to disclose. |
Kon Chu (Seoul National University Hospital) | No disclosure on file |
Pue Farooque, DO (NYU Langone) | No disclosure on file |
Jeffrey M. Gelfand, MD, MAS, FAAN (University of California, San Francisco) | Dr. Gelfand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. Dr. Gelfand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ventyx Bio. An immediate family member of Dr. Gelfand has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Headache: The Journal of Head and Face Pain. The institution of Dr. Gelfand has received research support from Genentech/Roche. The institution of Dr. Gelfand has received research support from Vigil Neurosciences. An immediate family member of Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant and Expert, Vaccine Injury Compensation Program with United States Health and Human Services and Department of Justice. Dr. Gelfand has a non-compensated relationship as a Trial Steering Committee Chairperson and member with Roche / Genentech that is relevant to AAN interests or activities. |
Michael D. Geschwind, MD, PhD, FAAN (UCSF) | Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Brainstorm Cell Therapeutics, Inc.. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Walter Grubb. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Reata Pharmaceuticals, Inc.. |
Ernest R. Somerville, FRACP | No disclosure on file |
No disclosure on file | |
Angela Vincent, MBBS, MSc (John Radcliffe Hospital) | Angela Vincent, MBBS,MSc has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Angela Vincent, MBBS,MSc has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Angela Vincent, MBBS,MSc has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Angela Vincent, MBBS,MSc has received intellectual property interests from a discovery or technology relating to health care. Angela Vincent, MBBS,MSc has received intellectual property interests from a discovery or technology relating to health care. |
Maria I. Leite, MD (Nuffield Department of Clinical Neurosciences - University of Oxford) | The institution of Dr. Leite has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Leite has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viela/Horizon. The institution of Dr. Leite has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Leite has received research support from Non-Profit Organization - Myaware. The institution of Dr. Leite has received research support from UCB - Ra Pharma. |
Patrick Waters, PhD (Oxford Autoimmune Neurology Diagnostic Lab - Nuffield Clinical Neurosciences) | Dr. Waters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Waters has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Waters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UBC. Dr. Waters has received intellectual property interests from a discovery or technology relating to health care. |
Sarosh R. Irani, MD, PhD, FRCP, FEAN (Mayo Clinic) | Dr. Irani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB, Cerebral therapeutics, Roche and Janssen. Dr. Irani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Irani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Irani has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Brain. Dr. Irani has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for LLPs. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care. |